Sat.Oct 26, 2019 - Fri.Nov 01, 2019

article thumbnail

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant

JAMA Internal Medicine

This cohort study examines the risk of bleeding and stroke associated with surgical procedures and the value of perioperative management among patients with atrial fibrillation who use anticoagulants.

98
article thumbnail

Mistakes to Be Avoided When Preparing a Drug Launch

Drug Patent Watch

The launch of a new product can be a daunting task. The main reason this happens is that no matter how many times your company has managed to enter new…. The post Mistakes to Be Avoided When Preparing a Drug Launch appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 63
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Use Halloween To Your Advantage

ECRG Media's Clinical Research Podcast

Use Halloween to Your Advantage Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Send in a voice mess

article thumbnail

Cost & Management of Oncology Combination Regimens

pharmaphorum

Overview Oncology treatment increasingly involves combinations of novel oral and biologic drugs. While combo approaches aren’t new, there are significant cost implications of combining high priced innovator drugs (versus older, generic chemotherapies). Payers are in a difficult spot regarding the cost and management of these regimens. Traditional utilization management tools are still difficult to apply in oncology, given no payer wants to be on the front page of a major newspaper for denying tr

Drugs 40
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Association Between Soft Drink Consumption and Mortality in Europe

JAMA Internal Medicine

This cohort study examines whether soft drink consumption is associated with all-cause and cause-specific mortality in a large cohort of European adults.

42
article thumbnail

Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984

Drug Patent Watch

This article was originally published by Garth Boehm, Lixin Yao, Liang Hana, and Qiang Zheng in Acta Pharmaceutica Sinica under a creative commons license. Abstract The key events in the…. The post Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984 appeared first on DrugPatentWatch - Make Better Decisions.

More Trending

article thumbnail

8 Questions You Have About Myasthenia Gravis And Pregnancy

Find Me Cure

Myasthenia gravis can change your path in unpredictable ways. Every aspect of your day-to-day life can be affected: from your job and hobbies to the way you eat and even sleep. You may need to reconsider things you took for granted or delay plans you had for your family or career. Among those plans that may need to be postponed is pregnancy. . The high prevalence of MG in women in their 20s and 30s makes family planning a difficult topic for many myasthenia patients.

article thumbnail

Recommended Reading: “The Toxic Nationalism of the Pharmaceutical Industry”

Pharmacy Checkers

Photo by Element5 Digital on Unsplash. This week, I simply want to bring your attention to an article in The New Republic called “ The Toxic Nationalism of the Pharmaceutical Industry.” Basically, the author Audrey Farley describes how the pharmaceutical industry has employed nationalism, racism, and prejudice in its communications and lobbying strategies that put profits over patients.

Drugs 43
article thumbnail

Should I Get A Clinical Research Certificate?

ECRG Media's Clinical Research Podcast

Should I Get A Clinical Research Certificate? In this episode we discuss those clinical research certifications and if they mean anything or if they can even help you get into the industry or get to your dream job. You may have heard about the CCRA, CCRP and many other ones. Hope this episode helps. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Wat

article thumbnail

Should I Get A Clinical Research Certificate?

ECRG Media's Clinical Research Podcast

Should I Get A Clinical Research Certificate? In this episode we discuss those clinical research certifications and if they mean anything or if they can even help you get into the industry or get to your dream job. You may have heard about the CCRA, CCRP and many other ones. Hope this episode helps. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Wat

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model